What We're Reading: Page 210
Industry reads hand-picked by our editors
Dec 02, 2019
-
The New York Times
New Strawberry-Flavored H.I.V. Drugs for Babies Are Offered at $1 a Day
-
POLITICO
Senate quicksand engulfs a bipartisan plan that Trump backs
-
The Wall Street Journal
GE Pitches Investors on Its Health-Care Unit, a Steady Source of Cash
Nov 27, 2019
-
Fortune
How Sanofi's Breakthrough Dengue Fever Vaccine Caused an Epidemic of Fear
-
POLITICO
Clashes among top HHS officials undermine Trump agenda
-
Reuters
Pfizer, Novartis lead pharma spending spree on gene therapy production
-
OneZero
There Still Aren’t Any Rules Preventing Rogue Scientists From Making Gene-Edited Babies
Nov 26, 2019
-
Bloomberg
HLB's Cancer Drug Won Plaudits But There Was No Award
-
Reuters
Blackstone to invest $400 million in gene therapy venture with Ferring
-
Financial Times
South Korea’s SK Biopharmaceuticals plans to raise $850m in IPO
-
Endpoints News
Ex-Purdue CEO stands to earn a huge windfall in Novartis' buyout of the Medicines Co
Nov 25, 2019
Nov 22, 2019
-
STAT
Gene therapy pioneer: Field is behind, and delivery tech is 'embarrassing'
-
Bloomberg
Sanofi Is Said to Mull Options for $30 Billion Consumer Arm
-
Reuters
Oklahoma to seek billions more from J&J over opioid crisis on appeal
-
The San Diego Union-Tribune
Union-Tribune biotech writer Bradley J. Fikes, beloved by colleagues, dies at 62
Nov 21, 2019
-
MIT Technology Review
A giant, superfast AI chip is being used to find better cancer drugs
-
Puget Sound Business Journal
Seattle Genetics CEO wants his company to be the face of area's biotech scene
-
Reuters
Charity to pay $4 million to resolve U.S. pharma kickback probe
-
Gizmodo
It's time to kick big pharma out of antibiotics research, scientists argue
Nov 20, 2019
-
The Wall Street Journal
Generic-Drug Approvals Soar, But Patients Still Go Without
-
Associated Press
OxyContin maker thrives in China with abandoned US tactics
-
Ventura County Star
Thousand Oaks-based biotech company Amgen eliminating jobs
Previous
